Angelic (Part 2)

Angelic (Part 2)

In March-15 when the stock was at ~$15.50 we highlighted HALO, a bio-tech company, in this post. Our interest in the name was entirely attributable to its very unique and favorable-looking ascending triangle pattern, which had been developing since 2004…....

Member only content: Login to view or Register
4 Years of Biotech Relative Outperformance Appears to Have Run its Course

4 Years of Biotech Relative Outperformance Appears to Have Run its Course

We’ve been bullish on biotech for a long, long time dating back to summer 2012 in posts outlined here and here. Despite many calling for tops in the space for quite some time, I’ve been reticent to do so, outlining…...

Member only content: Login to view or Register
261.8%, 423.6% and 35%

261.8%, 423.6% and 35%

261.8% – the Fib expansion level formed off the DJ Biotech Index’s 2000/2002 high and low, respectively, that the index ascended past in late November at ~1,350-1,400. 423.6% – the Fib expansion level formed off the DJ Biotech Index’s 2000/2002…...

Member only content: Login to view or Register
Up Nearly 70% in a Year, The DJ Biotech Index is Approaching our 1,400 Target; Now What?

Up Nearly 70% in a Year, The DJ Biotech Index is Approaching our 1,400 Target; Now What?

These guys are nearing the end of their cyclical runs. In July of last year we noted the group was working on a break-out.  In that post we suggested the group was highly compelling. We went on to update the…...

Member only content: Login to view or Register
Up 43% in Eight Months, What Next for Bio-techs?

Up 43% in Eight Months, What Next for Bio-techs?

All the way back on July 16th we began building a strong bullish case for out-performance in bio-techs.  The group is up 43% since then. Along with airlines, I would say bio-tech/healthcare was the group we focused the most amount…...

Member only content: Login to view or Register
Bio-Techs Approaching Near-Term Support

Bio-Techs Approaching Near-Term Support

We’ve been bullish on this group for as long as we can remember going back a full four months to this post. We’ve talked recently about the possibility for the group to remain a sustainable out-performer here. As of late…

Biotechs Should Continue to Out-Perform Materially

On July 16th we noted pharma and biotechs were working on noteworthy, long-term technical break-outs. Regarding those groups, we said the following in that prior post: “The set-up in bio-tech is the most compelling given that the DJ Bio-tech index has already…

Bio-Tech & Pharma Working on Break-Outs

Both bio-techs and pharmaceuticals are working on quality, long-term technical break-outs in the charts below. The set-up in bio-tech is the most compelling given that the DJ Bio-tech index has already cleared all-time highs from 2000. Should it break its next…...

Member only content: Login to view or Register
Bio-Techs, a Leadership Group, Face Stiff Resistance (Same Resistance Faced at top of SPX Bear Market Retracement Rallies in 2001/2008)

Bio-Techs, a Leadership Group, Face Stiff Resistance (Same Resistance Faced at top of SPX Bear Market Retracement Rallies in 2001/2008)

Below is a table (via Finviz.com) that details YTD industry performance – biotech has been a standout YTD, up 22% and in 11th place out of all industries. That said, in the chart below the group’s YTD rally, via the DJ…...

Member only content: Login to view or Register